Icon

LIQREV (NDA214952)- (EQ 10MG BASE/ML)

SILDENAFIL CITRATE CMP DEV LLC
EQ 10MG BASE/ML
No Yes
2038-Dec-24 Expired
None None
None No
LIQREV is a phosphodiesterase-5 (PDE-5) inhibitor indicated for the treatment of pulmonary arterial hypertension (PAH) (World Health Organization [WHO] Group I) in adults to improve exercise ability and delay clinical worsening.
0 0 0
Total Other Developers None
Drugs with Suitability No
EQ 10MG BASE/ML ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.